Corcept Therapeutics EBITDA 2010-2024 | CORT

Corcept Therapeutics EBITDA for the quarter ending September 30, 2024 was $0.047B, a 49.68% increase year-over-year.

  • Corcept Therapeutics 2023 EBITDA was 0.101B, a 14.43% decline from 2022.
  • Corcept Therapeutics 2022 EBITDA was 0.117B, a 11.71% decline from 2021.
  • Corcept Therapeutics 2021 EBITDA was 0.133B, a 1.99% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Corcept Therapeutics EBITDA 2010-2024 | CORT

  • Corcept Therapeutics 2023 EBITDA was 0.101B, a 14.43% decline from 2022.
  • Corcept Therapeutics 2022 EBITDA was 0.117B, a 11.71% decline from 2021.
  • Corcept Therapeutics 2021 EBITDA was 0.133B, a 1.99% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.